Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21-40 months of age. [electronic resource]
Producer: 19990708Description: 2030-5 p. digitalISSN:- 0264-410X
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.